|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64.52 CNY | +1.05% |
|
+2.28% | +8.31% |
| 04:26am | Hengrui Pharma Unit Secures Approval to Conduct Clinical Trial for Hypertension Drug | MT |
| 04:20am | Hengrui Pharma's Cancer Drug Obtains China Breakthrough Therapy Designation | MT |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +1.05% | +2.28% | +1.96% | -5.40% | +8.31% | +51.21% | +70.73% | -32.14% | +363.39% | 60.84B | ||
| -0.20% | +1.65% | +1.83% | +32.00% | +0.64% | +35.63% | +199.10% | +483.07% | +1,263.93% | 968B | ||
| +2.10% | +4.57% | -0.01% | +12.18% | +3.48% | +48.23% | +23.48% | +35.63% | +120.73% | 505B | ||
| -0.08% | -1.98% | -3.49% | -4.69% | -3.93% | +24.20% | +42.91% | +95.20% | +328.89% | 389B | ||
| -0.47% | +4.73% | +7.61% | +17.51% | +3.87% | +28.69% | +17.98% | +8.48% | +29.08% | 367B | ||
| -0.79% | +4.66% | +4.20% | +10.09% | +1.58% | +29.44% | +22.36% | +89.17% | +223.96% | 295B | ||
| -0.70% | -0.55% | +7.99% | +26.34% | +2.86% | +7.22% | -3.55% | +31.49% | +113.72% | 271B | ||
| -0.18% | +4.74% | +7.72% | +8.75% | +3.69% | +25.17% | +35.09% | +36.23% | +38.75% | 274B | ||
| +1.11% | +10.54% | +19.35% | +2.61% | +17.85% | -37.48% | -16.10% | +79.95% | +100.79% | 263B | ||
| -1.10% | -2.34% | -0.88% | +10.27% | -1.49% | +19.34% | +18.66% | +35.63% | +121.67% | 175B | ||
| -0.79% | +0.37% | +1.69% | +3.05% | -0.76% | +35.43% | +41.20% | +97.94% | +31.63% | 152B | ||
| -0.65% | -1.30% | -5.03% | +1.50% | +0.80% | -6.34% | -47.54% | -31.90% | -17.35% | 144B | ||
| -2.32% | -0.85% | -3.38% | -4.35% | -2.68% | -15.24% | -10.85% | +1.65% | +8.27% | 117B | ||
| -1.42% | -3.03% | -0.33% | +11.50% | +0.19% | +9.88% | +50.93% | +100.00% | +371.31% | 117B | ||
| +0.42% | +2.99% | +3.23% | +28.72% | +3.90% | +1.24% | -22.71% | -13.42% | -8.54% | 114B | ||
| -1.01% | +2.06% | +1.84% | +14.16% | +1.84% | +39.59% | +29.84% | +8.73% | +9.01% | 101B | ||
| +0.19% | -0.93% | -1.24% | +20.53% | +2.35% | +24.07% | +156.91% | +43.93% | +551.51% | 87.66B | ||
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | ||
| +0.48% | -8.22% | -4.73% | -19.78% | -6.20% | +44.41% | +58.36% | +118.21% | +395.72% | 49B | ||
| -1.18% | +2.12% | +12.86% | +18.73% | +3.83% | +21.82% | +22.59% | +31.59% | -10.76% | 50.76B | ||
| Average | -0.33% | +2.70% | +2.69% | +9.67% | +2.11% | +20.34% | +36.28% | +64.18% | +212.41% | 228.24B | |
| Weighted average by Cap. | -0.14% | +3.35% | +3.05% | +14.31% | +2.20% | +23.63% | +59.71% | +139.66% | +380.85% |
- Stock Market
- Equities
- 600276 Stock
- Sector Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















